How do you use Sotrovimab in a sentence? See 3 example sentences showing how this word appears in different contexts, plus the exact meaning.
Sotrovimab in a sentence
Sotrovimab meaning
A monoclonal antibody used to treat COVID-19
Using Sotrovimab
- The main meaning on this page is: A monoclonal antibody used to treat COVID-19
Context around Sotrovimab
- Average sentence length in these examples: 15.7 words
- Position in the sentence: 1 start, 2 middle, 0 end
- Sentence types: 3 statements, 0 questions, 0 exclamations
Corpus analysis for Sotrovimab
- In this selection, "sotrovimab" usually appears in the middle of the sentence. The average example has 15.7 words, and this corpus slice is mostly made up of statements.
- Around the word, include, antibody and resistance stand out and add context to how "sotrovimab" is used.
- Recognizable usage signals include developed a sotrovimab resistance mutation and firm s sotrovimab antibody therapy. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "sotrovimab" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with sotrovimab
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
The drugs, which include Sotrovimab and Evusheld, are delivered intravenously. (10 words)
The firm’s sotrovimab antibody therapy, created in collaboration with and marketed as Xevudy, remains a key asset. (18 words)
But researchers found the virus developed a sotrovimab-resistance mutation as early as 21 days after receiving the antibody. (19 words)
But researchers found the virus developed a sotrovimab-resistance mutation as early as 21 days after receiving the antibody. (19 words)
The firm’s sotrovimab antibody therapy, created in collaboration with and marketed as Xevudy, remains a key asset. (18 words)
The drugs, which include Sotrovimab and Evusheld, are delivered intravenously. (10 words)
Example sentences (3)
The drugs, which include Sotrovimab and Evusheld, are delivered intravenously.
The firm’s sotrovimab antibody therapy, created in collaboration with and marketed as Xevudy, remains a key asset.
But researchers found the virus developed a sotrovimab-resistance mutation as early as 21 days after receiving the antibody.